PERSISTENT MACROALBUMINURIA

Semaglutide ingredient can help protect kidney function in people with obesity: Study

​The remarkable secondary analysis from the SELECT (Semaglutide Effects on Heart Disease and Stroke in Patients with Overweight or Obesity) experiment, a randomised trial with a participant pool of 17,604 people, was unveiled by researchers today at the 61st ERA Congress.